Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $356.51 | 14 | 78.3% |
| Education | $99.00 | 1 | 21.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $169.76 | 4 | $0 (2021) |
| AbbVie Inc. | $111.21 | 6 | $0 (2020) |
| Genentech USA, Inc. | $99.00 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $55.51 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $20.03 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $80.92 | 1 | GlaxoSmithKline, LLC. ($80.92) |
| 2020 | $35.82 | 2 | AbbVie Inc. ($35.82) |
| 2019 | $246.81 | 7 | Genentech USA, Inc. ($99.00) |
| 2018 | $91.96 | 5 | AbbVie, Inc. ($54.15) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $80.92 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $19.25 | General |
| 01/08/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $55.63 | General |
| 07/10/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2019 | Regeneron Healthcare Solutions, Inc. | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/29/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Immunology | ||||||
| 05/17/2019 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Education | In-kind items and services | $99.00 | General |
| Category: BioOncology/Immunology | ||||||
| 02/15/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| 01/22/2019 | Regeneron Healthcare Solutions, Inc. | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Immunology | ||||||
| 10/09/2018 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2018 | Regeneron Healthcare Solutions, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 08/02/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 180 | 258 | $76,418 | $17,747 |
| 2022 | 4 | 145 | 216 | $61,135 | $14,256 |
| 2021 | 4 | 175 | 262 | $69,582 | $19,485 |
| 2020 | 1 | 27 | 27 | $10,503 | $2,935 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 147 | $44,247 | $10,187 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 51 | 51 | $20,043 | $4,924 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 43 | $9,202 | $2,055 | 22.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 12 | 17 | $2,926 | $581.09 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 55 | 105 | $31,165 | $7,458 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 42 | 42 | $16,474 | $3,739 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 51 | $10,610 | $2,435 | 22.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2022 | 12 | 18 | $2,886 | $624.64 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 47 | 112 | $28,784 | $8,346 | 29.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 70 | 70 | $27,230 | $7,167 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 45 | 64 | $11,264 | $3,398 | 30.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2021 | 13 | 16 | $2,304 | $575.40 | 25.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 27 | 27 | $10,503 | $2,935 | 27.9% |
About Dr. Jan Karczewski, M.D
Dr. Jan Karczewski, M.D is a Rheumatology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1902291099.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Karczewski, M.D has received a total of $455.51 in payments from pharmaceutical and medical device companies, with $80.92 received in 2021. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($356.51).
As a Medicare-enrolled provider, Karczewski has provided services to 527 Medicare beneficiaries, totaling 763 services with total Medicare billing of $54,423. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Warwick, RI
- Active Since 04/06/2015
- Last Updated 07/12/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902291099
Products in Payments
- BENLYSTA (Biological) $114.13
- Rituxan (Biological) $99.00
- Humira (Biological) $75.39
- KEVZARA (Biological) $36.70
- KEVZARA SARILUMAB INJECTION (Biological) $18.81
- RINVOQ (Drug) $16.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.